Scynexis (SCYX) Gross Margin (QoQ) (2013 - 2024)
Powered by 
Analysis
Scynexis (SCYX) Gross Margin (QoQ) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 25,330.00 |
| Dec 31, 2023 | -23,178.00 |
| Sep 30, 2023 | -2,120.00 |
| Jun 30, 2023 | 1,180.00 |
| Mar 31, 2023 | 74.00 |
| Dec 31, 2022 | -72.00 |
| Sep 30, 2022 | -125.00 |
| Jun 30, 2022 | 326.00 |
| Mar 31, 2022 | 1,383.00 |
| Dec 31, 2021 | 13.00 |
| Mar 31, 2015 | -5,363.00 |
| Dec 31, 2014 | -102,516.00 |
| Sep 30, 2014 | 46,956.00 |
| Jun 30, 2014 | 69,494.00 |
| Mar 31, 2014 | 1,858.00 |
| Dec 31, 2013 | -700.00 |
| Sep 30, 2013 | 830.00 |